
About J.R.S. Oryx Pharmaceuticals Pvt Ltd
Data last updated:
J.R.S. Oryx Pharmaceuticals Pvt Ltd is a private limited company based in Karnal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 April 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85110HR1993PTC031972. Its GSTIN is 06AAACJ4310K1ZV (Haryana).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹26.45 Lakh. It is led by directors Surinder Pal and Parveen Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 217& 218 Sector – 3 Hsiidc Industrial Area, Karnal, Haryana, India – 132001.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.75 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹94,000 (net margin 0.3%) and EBITDA of ₹31.43 Lakh (EBITDA margin 8.4%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years.
As per MCA filings, the company has open charges of ₹3.04 Cr and satisfied charges of ₹1.77 Cr on record. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jrsoryxpharma.com.
Company details
Contact details
J.R.S. Oryx Pharmaceuticals Pvt Ltd's registered office is in Karnal, Haryana. Its website is jrsoryxpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address217& 218 Sector – 3 Hsiidc Industrial Area, Karnal, Haryana, India – 132001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of J.R.S. Oryx Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.
Financials of J.R.S. Oryx Pharmaceuticals Pvt Ltd
FY 2025 filings availableJ.R.S. Oryx Pharmaceuticals Pvt Ltd reported revenue of ₹3.75 Cr (down 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 9% over three years, including a 13% fall in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31.43 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹94,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.4% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of J.R.S. Oryx Pharmaceuticals Pvt Ltd
J.R.S. Oryx Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surinder Pal | Director | 26 Apr 1993 | 33 Years 6 Months | Current |
| Parveen Goyal | Director | 05 Feb 2025 | 1 Years 9 Months | Current |
Auditor
J.R.S. Oryx Pharmaceuticals Pvt Ltd is audited by P CHOPRA & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P CHOPRA & CO | FY 2021 | 004957N |
Shareholding
The shareholding of J.R.S. Oryx Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Apr 2018 | 100215901 | Others | ₹3.04 Cr | Open | |
| 17 Sep 2020 | 100368825 | Others | ₹30 Lakh | Satisfied | |
| 09 Feb 2015 | 10573551 | L & T Finance Limited | ₹2.5 Lakh | Satisfied | |
| 18 Jun 2013 | 10438127 | Capital First Limited | ₹91.5 Lakh | Satisfied | |
| 26 May 2006 | 10012321 | Bank of Punjab Limited | ₹25 Lakh | Satisfied |
To see the full charge records of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 7 View all charges
Legal cases
J.R.S. Oryx Pharmaceuticals Pvt Ltd has 7 court cases on record: 3 filed by J.R.S. Oryx Pharmaceuticals, 4 filed against it. 1 case is pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 3 | 0 |
| District courts | 2 | 1 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (S) | Filed against the company by Galpha Laboratories Ltd | Disposed |
| Bombay High Court | Court case (LPETN) | Filed against the company by Galpha Laboratories Ltd | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Galpha Laboratories Ltd | Disposed |
| District court, Vizianagaram, Andhra Pradesh | Criminal case | Filed against the company | Pending |
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against individuals | Disposed |
To see the full case history of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for J.R.S. Oryx Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
J.R.S. Oryx Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACJ4310K1ZV | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
J.R.S. Oryx Pharmaceuticals Pvt Ltd has 5 board changes on record since 1993: 2 appointments and 3 cessations. The latest: Rattan Lal Sharma ceased to be Director on 10 Feb 2025.
12 earlier events are in the company report.
Frequently asked questions
J.R.S. Oryx Pharmaceuticals is an active private limited company based in Karnal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 April 1993 (33+ years old) and is registered under CIN U85110HR1993PTC031972.
J.R.S. Oryx Pharmaceuticals has 2 current directors:
- Surinder Pal - Director
- Parveen Goyal - Director
The latest financial statements of J.R.S. Oryx Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of J.R.S. Oryx Pharmaceuticals is 06AAACJ4310K1ZV, registered in Haryana.
The CIN (Corporate Identification Number) of J.R.S. Oryx Pharmaceuticals is U85110HR1993PTC031972. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
J.R.S. Oryx Pharmaceuticals has 7 court cases on record: 3 filed by the company and 4 filed against it. 1 is pending. Most are in the high courts.
J.R.S. Oryx Pharmaceuticals was incorporated on 16 April 1993, making it 33+ years old. It is registered with the Registrar of Companies, Delhi.
Rattan Lal Sharma ceased to be Director on 10 Feb 2025. Parveen Goyal was appointed as Director on 05 Feb 2025. Nathi Ram Verma ceased to be Director on 01 Apr 2013. J.R.S. Oryx Pharmaceuticals has 5 board changes on record in total.
J.R.S. Oryx Pharmaceuticals can be reached through the website jrsoryxpharma.com. Its registered office is in Karnal, Haryana, India.
The registered office of J.R.S. Oryx Pharmaceuticals is at 217& 218 Sector – 3 Hsiidc Industrial Area, Karnal, Haryana, India – 132001.

